Morgan Stanley raised the firm’s price target on Sanofi to EUR 108 from EUR 100 and keeps an Equal Weight rating on the shares.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SNY:
- Sanofi says once-weekly Altuviiio approved in Japan
- MacroGenics, Aventis mutually terminate Royalty Purchase Agreement
- Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
- First Wave (NASDAQ:FWBI) Skyrockets on Sanofi Licensing Deal
- First Wave BioPharma licenses Sanofi’s Capeserod for gastrointestinal disorders